Clinical Trial Update: Study to Evaluate Adverse Events, Change in Disease Activity, and How Oral ABBV-101 Moves Through the Body in Adult Participants With B-Cell Malignancies [Phase 1]

View source ↗

Summary

This Phase 1 trial update describes evaluating ABBV-101 in adults with B-cell malignancies to assess adverse events, changes in disease activity, and pharmacoki…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• B-cell Malignancies

Drugs mentioned

• ABBV-101

Snippet

Sponsor: AbbVie | Conditions: Hematologic Cancer | Phase 1 | Status: ACTIVE_NOT_RECRUITING